Study identifier:NIS-CIN-XXX-2011/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Study to derive normative distribution of CIMT and to determine its correlation with cardiovascular Risk factors in asymptomatic nationwide Indian population (SCORE India)
Carotid Intima- Media Thickness
-
Yes
-
All
1200
Observational
30 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jul 2014 by AstraZeneca
AstraZeneca
-
This non-interventional, prospective, multi-centric, cross-sectional study is aimed to obtain the distribution of measurements of CIMT in Indian subjects and will involve approx. 30 investigative sites from all over the country. Each investigative site will be expected to enrol 50 subjects and Carotid intima-media thickness (CIMT) values will be taken for each individual as described in the protocol. All the procedures could be completed in a single day, however due to any reason any study variable is not taken subject may be asked to come back for a second visit within 7 days of the first visit.
A Study to derive normative distribution of CIMT and to determine its cOrrelation with cardiovascular Risk factors in asymptomatic nationwidE Indian population. (SCORE India)
Location
Location
Gurgaon, Haryana, India
Location
Delhi, New Delhi, India
Location
Noida, UP, India
Location
Vadodara, Gujarat, India
Location
Ahmedabad, Gujarat, India
Location
Mumbai, Maharashtra, India
Location
Indore, India
Location
Nampally, Hyderabad, India
Arms | Assigned Interventions |
---|---|
subjects who are meeting the inclusion criteria | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.